NeuroBo Pharmaceuticals I... (NRBO)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
2.36
0.01 (0.43%)
At close: Nov 27, 2024, 9:00 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
PE Ratio | -1.5 | -0.3 | -1.85 | -2.88 | -2.04 | -29.14 | -19.68 | -24.98 | -43.21 | -1.22K |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.12 | 0.08 | 1.93 | 11.82 | 3.72 | -9.02 | 166.90 | 17.66 | -31.51 | -734.75 |
P/FCF Ratio | -1.73 | -0.16 | -1.87 | -7.91 | -6.3 | -31.43 | -24.45 | -32.99 | -71.81 | -2.00K |
P/OCF Ratio | -1.74 | -0.16 | -1.87 | -7.91 | -6.49 | -31.43 | -24.45 | -32.99 | -71.81 | -2.00K |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.00 | n/a | 0.00 | 0.00 | 0.00 | -0.13 | 2.55 | n/a | -0.52 | -1.39 |
Quick Ratio | 3.78 | 2.85 | 7.69 | 2.89 | 6.78 | 2.01 | 2.97 | 6.00 | 0.41 | 0.38 |
Current Ratio | 3.78 | 2.85 | 7.69 | 2.89 | 6.78 | 2.01 | 2.97 | 6.00 | 0.41 | 0.38 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -8.96 | n/a | -761.95 | -917.09 | -34.87 | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -0.75 | -0.28 | -1.04 | -4.11 | -1.82 | 0.31 | -8.48 | -0.71 | 0.73 | 0.60 |
Return on Assets (ROA) | -0.55 | -0.18 | -0.91 | -2.7 | -1.55 | -1.2 | -1.76 | -0.59 | -2.01 | -0.92 |
Return on Capital (ROIC) | -0.94 | -0.9 | -1.04 | -4.09 | -1.63 | -2.22 | -2.62 | -0.71 | 1.82 | 0.50 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |